DANVILOSTOMIG
UNII B4Q67YX49Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Danvilostomig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B4Q67YX49Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2599198-80-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B4Q67YX49Q
CAS Registry Number
2599198-80-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DANVILOSTOMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12198
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Danvilostomig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DANVILOSTOMIG

Common Names & Synonyms

DANVILOSTOMIG [INN]
IMMUNOGLOBULIN G1 (235-ALANINE,236-ALANINE,238-ALANINE,322-ALANINE,DE-448-LYSINE), BISPECIFIC, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL MDX010 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-ORYCTOLAGUS CUNICULUS CLONE PD224D1 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)4-VL), DISULFIDE WITH HUMAN MONOCLONAL MDX010 .KAPPA.-CHAIN, DIMER